Mortality and morbidity associated with osteoporosis drug treatment following hip fracture

@article{Cree2003MortalityAM,
  title={Mortality and morbidity associated with osteoporosis drug treatment following hip fracture},
  author={Marilyn Wanda. Cree and Angela G. Juby and K. C. Carriere},
  journal={Osteoporosis International},
  year={2003},
  volume={14},
  pages={722-727}
}
This study examined post-fracture osteoporosis drug treatment in hip fracture patients and the association of treatment with mortality and morbidity. Pre- and post-fracture demographic/health information was collected on a cohort of hip fracture patients aged 65+ years. Post-fracture administrative data on prescription drug use and health care utilization was linked to the cohort data. Five classes of osteoporosis drugs were available during the study period: hormone replacement therapy (HRT… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 36 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

Canadian consensus on menopause and osteoporosis: osteoporosis

  • CK Yuen, D Kendler, A Khan, J Brown, M Fortier
  • J Obstet Gynecol Can :XX1–XX11
  • 2001
1 Excerpt

Similar Papers

Loading similar papers…